Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone. [electronic resource]
Producer: 20151013Description: 1329-38 p. digitalISSN:- 1097-0045
- Adult
- Aged
- Aged, 80 and over
- Androstenes -- adverse effects
- Disease Progression
- Disease-Free Survival
- Enzyme Inhibitors -- adverse effects
- Humans
- Male
- Metabolic Syndrome -- complications
- Middle Aged
- Prostatic Neoplasms, Castration-Resistant -- complications
- Retrospective Studies
- Risk Factors
- Steroid 17-alpha-Hydroxylase -- antagonists & inhibitors
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.